Loading...
Glucosamine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Glucosamine
2025-Q4
Comprehensive analysis of India’s glucosamine export trade — suppliers, buyers, prices, routes, and every shipment record.
48
Shipments
$692K
Trade Value
24
Suppliers
23
Buyers
21
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/glucosamine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s glucosamine trade — 2025-Q4
KEY TAKEAWAY
Glucosamine 2025-Q4 exports total $692.1K across 21 countries, with SAVA HEALTHCARE LTD commanding 27.5% market share.
TOTAL SHIPMENTS
48
2025-Q4
EXPORT VALUE
$692.1K
FOB USD
TOTAL QUANTITY
3.3M
units shipped
INDIAN SUPPLIERS
24
unique exporters
GLOBAL BUYERS
23
unique importers
DESTINATIONS
21
countries
MEDIAN UNIT PRICE
$1.99
per unit
TOP-5 SHARE
78.4%
of total USD
BRANDED SHARE
83.3%
40 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
SAVA HEALTHCARE LTD is India's #1 Glucosamine exporter with $190.3K (27.5% market share).→ §5, Indian Supplier Rankings
2
Glucosamine reached 21 countries, with Romania as the top destination ($189.1K).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 1575) — top 10 suppliers control 97.4% of exports.→ §5, Indian Supplier Rankings
4
91.3% of buyers (21 of 23) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (63.1%) across 5 dosage forms.→ §7, Price Benchmarks
6
21 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 SAVA HEALTHCARE LTD leads in volume — how do 24 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian glucosamine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Glucosamine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial glucosamine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian glucosamine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Glucosamine India trade report
Product scope
Glucosamine
All variants merged — branded and generic formulations of glucosamine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
48
Every commercial glucosamine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $142.4K, Nov $159.9K, Dec $389.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$142.4K
Oct USD
9 shipments
2
$159.9K
Nov USD
+12.2% MoM
3
$389.8K
Dec USD
+143.8% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 12.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $142K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $692K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $17K rise in Nov, $230K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $142K | 9 shipments |
| Nov | $160K | 12 shipments |
| Dec | $390K | 27 shipments |
| Q4 Total | $692K | 48 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Romania held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SAVA HEALTHCARE LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import glucosamine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Romania absorbs 27.3% of India’s 2025-Q4 glucosamine trade ($189.1K). Beyond the top 10 destinations, 21 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 9 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 21 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much glucosamine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$102K
14.7% of trade
5 countries · 12 shipments
Europe
$438K
63.3% of trade
4 countries · 18 shipments
Americas
$75K
10.8% of trade
3 countries · 4 shipments
Africa
$78K
11.2% of trade
9 countries · 14 shipments
Fig 4.1 Romania is the #1 corridor ($189K) — 21 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian glucosamine it receives (light = low, dark = high). Orange arcs radiate from India to the top 21 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Romania | $189K | 7 | SAVA HEALTHCARE LTD | $189K | — | — | — | — |
| 2 | France | $148K | 4 | TROIKAA PHARMACEUTICALS LTD | $133K | MEDNEXT BIOTECH LTD | $15K | — | — |
| 3 | Russia | $100K | 3 | PANACEA BIOTEC PHARMA LTD | $100K | — | — | — | — |
| 4 | Singapore | $67K | 1 | MEDREICH LTD | $67K | — | — | — | — |
| 5 | El Salvador | $46K | 1 | CAPLIN POINT LABORATORIES LTD | $46K | — | — | — | — |
| 6 | Nigeria | $43K | 2 | ASOJ SOFT CAPS PVT LTD | $43K | — | — | — | — |
| 7 | Ghana | $29K | 1 | THE MADRAS PHARMACEUTICALS | $29K | — | — | — | — |
| 8 | Guatemala | $27K | 2 | XL LABORATORIES PVT LTD | $27K | — | — | — | — |
| 9 | Kazakhstan | $18K | 1 | OXFORD LABORATORIES PVT LTD | $18K | — | — | — | — |
| 10 | Afghanistan | $10K | 4 | ANVIS LABORATORIES PVT LTD | $6K | ZEE LABORATORIES LTD | $4K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 14.7% of USD — but Romania is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
27.3%
#1 country share
Romania alone
79.4%
Top 5 share
5 of 21 countries
99.8%
Top 15 share
Long tail of 6 countries = 0.2%
HHI 1631
Destination HHI
Moderately concentrated
21
Countries served
Global pharma reach from India
9
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
24 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
SAVA HEALTHCARE LTD ($190.3K, 27.5% share) and TROIKAA PHARMACEUTICALS LTD ($133.2K) together control 46.7% of India’s 2025-Q4 glucosamine trade. The top 5 suppliers hold 78.4%. 24 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian glucosamine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SAVA HEALTHCARE LTD leads by $57K over TROIKAA PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MERCURY MEDICARE is #20 by value but #11 by volume.
Fig 5.2 SAVA HEALTHCARE LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MERCURY MEDICARE moves from #11 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 24 glucosamine suppliers split into strategic segments
KEY TAKEAWAY
6 suppliers (25%) generate 84.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SAVA HEALTHCARE LTD and TROIKAA PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 84.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MEDREICH LTD | 2 | 2 | $74K |
| 2 | SAVA HEALTHCARE LTD | 1 | 2 | $190K |
| 3 | TROIKAA PHARMACEUTICALS LTD | 1 | 1 | $133K |
| 4 | PANACEA BIOTEC PHARMA LTD | 1 | 1 | $100K |
| 5 | CAPLIN POINT LABORATORIES LTD | 1 | 1 | $46K |
| 6 | ASOJ SOFT CAPS PVT LTD | 1 | 1 | $43K |
| 7 | THE MADRAS PHARMACEUTICALS | 1 | 1 | $29K |
| 8 | XL LABORATORIES PVT LTD | 1 | 1 | $27K |
| 9 | MEDNEXT BIOTECH LTD | 1 | 1 | $15K |
| 10 | ANVIS LABORATORIES PVT LTD | 1 | 1 | $6K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the glucosamine manufacturing hubs
KEY TAKEAWAY
Wadhwan City and Mahesana together account for $324K of India’s 2025-Q4 glucosamine trade.
Fig 5.5 Wadhwan City (1 exporters, $190K) and Mahesana (1 exporters, $133K) are India’s glucosamine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
78.4%
Top 5 share
5 of 24 suppliers
97.4%
Top 10 share
10 of 24 suppliers
84.6%
Top 25% share
6 suppliers = 85% USD
HHI 1575
Supplier HHI
Moderate
24
Total suppliers
shipped Glucosamine in 2025-Q4
19+ cities
Indian hubs
Wadhwan City and Mahesana lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | SAVA HEALTHCARE LTD | $190K |
#1
EXPORTER PROFILE #1 OF 1
SAVA HEALTHCARE LTD
Wadhwan City · India’s #1 glucosamine supplier by USD · 2025-Q4
2025-Q4 USD
$190K
27.5% market share
SHIPMENTS
11
avg $17K/ship
COUNTRIES
2
destination markets
BUYERS
1
1 single-sourced
BRANDED
91%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Romania is the #1 market at $189K (99% of trade), followed by Ukraine at $1K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Romania | $189K | 7 | 99.3% |
| 2 | Ukraine | $1K | 4 | 0.7% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $170K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 1/1 LOCKED IN
1 of 1 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MOVI HEALTH LLC | Romania | $190K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
SAVA HEALTHCARE LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Romania absorbs $189K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
23 importers across 21 countries — who is buying Indian glucosamine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 21 importers together hold only 74.5% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian glucosamine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MOVI HEALTH LLC is the #1 importer at $190K (27.5%) — top 21 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 21 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
21 buyers rely on exactly 1 Indian supplier
4%
Dual-source
1 buyers use 2 Indian suppliers
4%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source glucosamine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Malaysia 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HEALOL PHARMACEUTICALS… | MEDREICH LTD | $7K | $3.347 | Tablet |
| GKV GLOBAL SERVICES | GOOD HEALTH PHARMA | $71.863 | $0.599 | Other |
| SEQUENCE MEDICARE SDN … | MERCURY MEDICARE | $58.648 | $0.586 | Tablet |
Afghanistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARIA PHRAMA CO LTD | ANVIS LABORATORIES P… | $6K | $0.496 | Tablet |
| NAWI FAQIRI LTD | ZEE LABORATORIES LTD | $4K | $0.536 | Tablet |
Romania 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MOVI HEALTH LLC | SAVA HEALTHCARE LTD | $190K | $4.845 | Tablet |
Russia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PANBIO PHARM LLC | PANACEA BIOTEC PHARM… | $100K | $0.043 | Capsule |
Singapore 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMAZEN MEDICALS PTE… | MEDREICH LTD | $67K | $13.705 | Capsule |
§6.3 Price positioning — top 21 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MOVI HEALTH LLC | Romania | $190K | $17K | Mid |
| 2 | PANBIO PHARM LLC | Russia | $100K | $33K | Mid |
| 3 | PHARMAZEN MEDICALS P… | Singapore | $67K | $67K | Premium |
| 4 | DROGUERIA SAIMED S.A… | El Salvador | $46K | $46K | Premium |
| 5 | LYMENS MEDICAL SUPPL… | Ghana | $29K | $29K | Mid |
| 6 | FUTURA, SOCIEDAD ANO… | Guatemala | $27K | $14K | Budget |
| 7 | TOO ANADHI | Kazakhstan | $18K | $18K | Mid |
| 8 | EURIMEX PHARMAPARC D… | France | $15K | $15K | Mid |
| 9 | HEALOL PHARMACEUTICA… | Malaysia | $7K | $7K | Budget |
| 10 | ARIA PHRAMA CO LTD | Afghanistan | $6K | $3K | Budget |
| 11 | NAWI FAQIRI LTD | Afghanistan | $4K | $2K | Budget |
| 12 | LEGIT MEDIQ 2007 LTD | Kenya | $3K | $3K | Budget |
| 13 | SONIA PHARMACY | Equatorial Guinea | $1K | $1K | Budget |
| 14 | PROPHARMA S.A | Haiti | $1K | $1K | Budget |
| 15 | LIFELINE PHARMACEUTI… | Lesotho | $699.205 | $350.000 | Budget |
| 16 | KALKAAL HOSPITAL | Somalia | $581.361 | $581.000 | Budget |
| 17 | COCIETE BIKA MULTI A… | Chad | $109.813 | $110.000 | Budget |
| 18 | GKV GLOBAL SERVICES | Malaysia | $71.863 | $72.000 | Budget |
| 19 | SEQUENCE MEDICARE SD… | Malaysia | $58.648 | $29.000 | Budget |
| 20 | BAPA KAZADI | DR Congo | $36.855 | $37.000 | Budget |
| 21 | GOOD HEALTH (PTY) LTD | Seychelles | $1.913 | $2.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 SAVA HEALTHCARE LTD → MOVI HEALTH LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian glucosamine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Glucosamine prices span 48578× ($0.0006 → $29.70). The coefficient of variation is 1.54. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0006 | Lowest observed unit price |
| P5 | $0.016 | 5th percentile |
| P25 | $0.497 | 25th percentile (Q1) |
| Median | $1.99 | 50th percentile (Q2) |
| P75 | $4.07 | 75th percentile (Q3) |
| P95 | $9.23 | 95th percentile |
| Max | $29.70 | Highest observed unit price |
| Mean | $3.11 | Arithmetic average |
| CV | 154% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 REGAL LABORATORIES prices at $29.70/unit vs market median $1.99.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. PANACEA BIOTEC PHARMA Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SAVA HEALTHCARE LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. CAPLIN POINT LABORATORIES Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. THE MADRAS PHARMACEUTICALS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 45 | $1K | $29.70 | Specialty / small-batch |
| Dec 2025 | MEDREICH LTD | Singapore | Capsule | 5K | $67K | $13.71 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Romania | Tablet | 5K | $45K | $9.72 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Romania | Tablet | 2K | $19K | $8.09 | Specialty / small-batch |
| Oct 2025 | MEDNEXT BIOTECH … | France | Tablet | 3K | $15K | $5.23 | Specialty / small-batch |
| Nov 2025 | COMED CHEMICALS … | Kenya | Tablet | 610 | $3K | $5.23 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Romania | Tablet | 9K | $43K | $4.76 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Ukraine | Tablet | 120 | $571.57 | $4.76 | Specialty / small-batch |
| Oct 2025 | SAVA HEALTHCARE … | Romania | Tablet | 4K | $21K | $4.63 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Romania | Tablet | 5K | $19K | $4.08 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | VEA IMPEX (I) PV… | Seychelles | Tablet | 100 | $1.52 | $0.015 | Small sample / trial shipment |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Tablet | 1K | $15.60 | $0.016 | |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Tablet | 1K | $15.60 | $0.016 | |
| Dec 2025 | AL-SUPREME EXPORTS | Seychelles | Tablet | 60 | $1.91 | $0.032 | Small sample / trial shipment |
| Nov 2025 | PANACEA BIOTEC P… | Russia | Capsule | 665K | $32K | $0.049 | |
| Dec 2025 | PANACEA BIOTEC P… | Russia | Capsule | 1.3M | $67K | $0.050 | Bulk volume discount |
| Nov 2025 | CAPLIN POINT LAB… | El Salvador | Tablet | 768K | $46K | $0.060 | |
| Nov 2025 | BAKER & DAVIS PV… | Chad | Tablet | 1K | $109.81 | $0.110 | |
| Nov 2025 | BAKER & DAVIS PV… | Chad | Tablet | 1K | $109.81 | $0.110 | |
| Nov 2025 | RUSHI MARKETING | DR Congo | — | 200 | $36.86 | $0.184 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship glucosamine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Glucosamine leaves India through 16+ ports. The top 5 (MUNDRA SEA, AHMEDABAD ICD, DELHI AIR) handle 83.5% of total USD. SEA moves 31% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUNDRA SEA handles $232K — top 16 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Constanta is the #1 global destination port — top 24 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 31% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$323K
46.6% of USD · 31.3% of ships
ICD
$240K
34.7% of USD · 25.0% of ships
AIR
$129K
18.7% of USD · 43.8% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → Europe ($189K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Romania is the most concentrated destination (HHI 10000, 1 suppliers). Afghanistan is the most competitive (HHI 5131).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Romania (HHI 10,000) is the most concentrated — Afghanistan (HHI 5,131) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MOVI HEALTH LLC | Romania | SAVA HEALTHCARE … | $190K | 11 | HIGH |
| PANBIO PHARM LLC | Russia | PANACEA BIOTEC P… | $100K | 3 | MEDIUM |
| PHARMAZEN MEDICALS P… | Singapore | MEDREICH LTD | $67K | 1 | MEDIUM |
| DROGUERIA SAIMED S.A… | El Salvador | CAPLIN POINT LAB… | $46K | 1 | MEDIUM |
| LYMENS MEDICAL SUPPL… | Ghana | THE MADRAS PHARM… | $29K | 1 | MEDIUM |
| FUTURA, SOCIEDAD ANO… | Guatemala | XL LABORATORIES … | $27K | 2 | MEDIUM |
| TOO ANADHI | Kazakhstan | OXFORD LABORATOR… | $18K | 1 | MEDIUM |
| EURIMEX PHARMAPARC D… | France | MEDNEXT BIOTECH … | $15K | 1 | MEDIUM |
Conclusion: 21 buyers depend on exactly one Indian supplier, representing $516K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Romania | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Russia | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| El Salvador | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Guatemala | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Kazakhstan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Ukraine | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Haiti | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Romania | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Romania lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Malaysia (3 suppliers) | This Q | HIGH |
| A6 | Enter Romania (1 suppliers) | This Q | MED |
| A8 | Build France distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Romania tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Malaysia | Asia | 3 | $7K | +23364.3% | LOW | Growing 23364% with only 3 competitors |
| 2 | Romania | Other | 1 | $189K | +709.1% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | France | Other | 2 | $148K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Russia | Other | 1 | $100K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Singapore | Asia | 1 | $67K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | El Salvador | Other | 1 | $46K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Nigeria | Africa | 1 | $43K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Ghana | Africa | 1 | $29K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Guatemala | Other | 1 | $27K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Kazakhstan | Asia | 1 | $18K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Afghanistan | Asia | 2 | $10K | +38.7% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Kenya | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Equatorial Guinea | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Ukraine | Other | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Haiti | Other | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 48 2025-Q4 Glucosamine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/glucosamine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 48 2025-Q4 glucosamine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian glucosamine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
48
across all regions
TOTAL USD
$692K
2025-Q4 FOB value
UNITS
3.3M
tablets, capsules, etc.
SUPPLIERS
24
Indian exporters
BUYERS
23
global importers
COUNTRIES
21
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $78K (11.2%), spanning 9 countries.
24 Indian suppliers shipped to 23 buyers across 21 countries — average shipment value $14K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
9 countries · 14 shipments · $78K · 10 Indian suppliers · 10 buyers
SHIPMENTS
14
USD
$78K
COUNTRIES
9
SUPPLIERS
10
BUYERS
10
HHI
4,446
concentrated
Top 9 destination countries in Africa
1
Nigeria (55.5%)
$43K
2
Ghana (36.7%)
$29K
3
Kenya (4.1%)
$3K
4
Equatorial Guinea (1.7%)
$1K
5
Lesotho (0.9%)
$699.21
6
Somalia (0.7%)
$581.36
7
Chad (0.3%)
$219.63
8
DR Congo (0.0%)
$36.86
9
Seychelles (0.0%)
$31.87
Top 10 Indian suppliers into Africa
1
ASOJ SOFT CAPS PVT LTD
$43K
2
THE MADRAS PHARMACEUTICALS
$29K
3
COMED CHEMICALS LTD
$3K
4
REGAL LABORATORIES
$1K
5
NUMED PHARMA DISTRIBUTOR
$699.21
6
CURE EARTH PHARMA
$581.36
7
BAKER & DAVIS PVT LTD
$219.63
8
RUSHI MARKETING
$36.86
9
VEA IMPEX (I) PVT LTD
$29.96
10
AL-SUPREME EXPORTS
$1.91
Top 8 Africa importers
1
LYMENS MEDICAL SUPPLIES LTD · Ghana
$29K
2
LEGIT MEDIQ 2007 LTD · Kenya
$3K
3
SONIA PHARMACY · Equatorial Guinea
$1K
4
LIFELINE PHARMACEUTICALS OF · Lesotho
$699.21
5
KALKAAL HOSPITAL · Somalia
$581.36
6
COCIETE BIKA MULTI ACTIVITIES · Chad
$109.81
7
BAPA KAZADI · DR Congo
$36.86
8
GOOD HEALTH (PTY) LTD · Seychelles
$1.91
Top 4 dosage forms
1
Softgel Capsule
$43K
2
Tablet
$34K
3
Capsule
$581.36
4
Unknown
$36.86
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $5K | $781.06 |
| Dec | 7 | $72K | $10K |
Shipment register · 14 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ASOJ SOFT CAPS PVT LTD · 2 shipments · $43K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Nigeria | Softgel Capsule | 15.5K | NOS | $1.11 | $17K | MUNDRA SEA | Apapa | SEA |
| 2 | Dec 2025 | UNLISTED BUYER | Nigeria | Softgel Capsule | 13.0K | NOS | $1.99 | $26K | MUNDRA SEA | Apapa | SEA |
| SUPPLIER #2 — THE MADRAS PHARMACEUTICALS · 1 shipments · $29K | |||||||||||
| 3 | Dec 2025 | LYMENS MEDICAL SUPPLIES LTD | Ghana | Tablet | 10.0K | PCS | $2.85 | $29K | CHENNAI SEA | Tema | SEA |
| SUPPLIER #3 — COMED CHEMICALS LTD · 1 shipments · $3K | |||||||||||
| 4 | Nov 2025 | LEGIT MEDIQ 2007 LTD | Kenya | Tablet | 610 | NOS | $5.23 | $3K | AHMEDABAD AIR | NAIROBI | AIR |
| SUPPLIER #4 — REGAL LABORATORIES · 1 shipments · $1K | |||||||||||
| 5 | Nov 2025 | SONIA PHARMACY | Equatorial Guinea | Tablet | 45 | KGS | $29.70 | $1K | CHAWAPAYAL ICD | MALABO | ICD |
| SUPPLIER #5 — NUMED PHARMA DISTRIBUTOR · 2 shipments · $699.21 | |||||||||||
| 6 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 1.0K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 7 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 1.0K | NOS | $0.699 | $699.21 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #6 — CURE EARTH PHARMA · 1 shipments · $581.36 | |||||||||||
| 8 | Dec 2025 | KALKAAL HOSPITAL | Somalia | Capsule | 1.0K | NOS | $0.581 | $581.36 | CHENNAI AIR | MOGADISCHU | AIR |
| SUPPLIER #7 — BAKER & DAVIS PVT LTD · 2 shipments · $219.63 | |||||||||||
| 9 | Nov 2025 | COCIETE BIKA MULTI ACTIVITIES | Chad | Tablet | 1.0K | NOS | $0.110 | $109.81 | MUMBAI AIR (SAHAR) | N'DJAMENA | AIR |
| 10 | Nov 2025 | UNKNOWN BUYER | Chad | Tablet | 1.0K | NOS | $0.110 | $109.81 | MUMBAI AIR (SAHAR) | N'DJAMENA | AIR |
| SUPPLIER #8 — RUSHI MARKETING · 1 shipments · $36.86 | |||||||||||
| 11 | Nov 2025 | BAPA KAZADI | DR Congo | 200 | NOS | $0.184 | $36.86 | AHMEDABAD AIR | KINSHASA | AIR | |
| SUPPLIER #9 — VEA IMPEX (I) PVT LTD · 2 shipments · $29.96 | |||||||||||
| 12 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 20 | NOS | $1.42 | $28.44 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 100 | NOS | $0.015 | $1.52 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #10 — AL-SUPREME EXPORTS · 1 shipments · $1.91 | |||||||||||
| 14 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 60 | NOS | $0.032 | $1.91 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 12 shipments · $102K · 7 Indian suppliers · 8 buyers
SHIPMENTS
12
USD
$102K
COUNTRIES
5
SUPPLIERS
7
BUYERS
8
HHI
5,597
concentrated
Top 5 destination countries in Asia
1
Singapore (65.7%)
$67K
2
Kazakhstan (17.4%)
$18K
3
Afghanistan (10.1%)
$10K
4
Malaysia (6.8%)
$7K
5
Iraq (0.0%)
$31.21
Top 7 Indian suppliers into Asia
1
MEDREICH LTD
$74K
2
OXFORD LABORATORIES PVT LTD
$18K
3
ANVIS LABORATORIES PVT LTD
$6K
4
ZEE LABORATORIES LTD
$4K
5
GOOD HEALTH PHARMA
$71.86
6
MERCURY MEDICARE
$58.65
7
DISTINCT IMPEX PVT LTD
$31.21
Top 7 Asia importers
1
PHARMAZEN MEDICALS PTE LTD · Singapore
$67K
2
TOO ANADHI · Kazakhstan
$18K
3
HEALOL PHARMACEUTICALS SDN BHD · Malaysia
$7K
4
ARIA PHRAMA CO LTD · Afghanistan
$6K
5
NAWI FAQIRI LTD · Afghanistan
$4K
6
GKV GLOBAL SERVICES · Malaysia
$71.86
7
SEQUENCE MEDICARE SDN BHD · Malaysia
$58.65
Top 4 dosage forms
1
Capsule
$67K
2
Unknown
$18K
3
Tablet
$17K
4
Other
$71.86
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $4K | $1K |
| Nov | 2 | $18K | $9K |
| Dec | 7 | $80K | $11K |
Shipment register · 12 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MEDREICH LTD · 2 shipments · $74K | |||||||||||
| 1 | Dec 2025 | PHARMAZEN MEDICALS PTE LTD | Singapore | Capsule | 4.9K | NOS | $13.71 | $67K | BANGALORE ICD | SINGAPORE | ICD |
| 2 | Dec 2025 | HEALOL PHARMACEUTICALS SDN BHD | Malaysia | Tablet | 2.0K | NOS | $3.35 | $7K | BANGALORE AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #2 — OXFORD LABORATORIES PVT LTD · 1 shipments · $18K | |||||||||||
| 3 | Nov 2025 | TOO ANADHI | Kazakhstan | 6.4K | NOS | $2.74 | $18K | MUMBAI AIR (SAHAR) | ALMATY | AIR | |
| SUPPLIER #3 — ANVIS LABORATORIES PVT LTD · 2 shipments · $6K | |||||||||||
| 4 | Dec 2025 | ARIA PHRAMA CO LTD | Afghanistan | Tablet | 9.9K | NOS | $0.458 | $5K | REWARI ICD | KANDAHAR | ICD |
| 5 | Dec 2025 | ARIA PHRAMA CO LTD | Afghanistan | Tablet | 2.1K | NOS | $0.672 | $1K | REWARI ICD | KANDAHAR | ICD |
| SUPPLIER #4 — ZEE LABORATORIES LTD · 2 shipments · $4K | |||||||||||
| 6 | Oct 2025 | NAWI FAQIRI LTD | Afghanistan | Tablet | 4.0K | NOS | $0.536 | $2K | SONEPAT ICD | AFKBL | ICD |
| 7 | Oct 2025 | NAWI FAQIRI LTD | Afghanistan | Tablet | 4.0K | NOS | $0.536 | $2K | SONEPAT ICD | AFKBL | ICD |
| SUPPLIER #5 — GOOD HEALTH PHARMA · 1 shipments · $71.86 | |||||||||||
| 8 | Dec 2025 | GKV GLOBAL SERVICES | Malaysia | Other | 120 | NOS | $0.599 | $71.86 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #6 — MERCURY MEDICARE · 2 shipments · $58.65 | |||||||||||
| 9 | Oct 2025 | SEQUENCE MEDICARE SDN BHD | Malaysia | Tablet | 50 | NOS | $0.588 | $29.40 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
| 10 | Nov 2025 | SEQUENCE MEDICARE SDN BHD | Malaysia | Tablet | 50 | NOS | $0.585 | $29.24 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #7 — DISTINCT IMPEX PVT LTD · 2 shipments · $31.21 | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 1.0K | NOS | $0.016 | $15.60 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 1.0K | NOS | $0.016 | $15.60 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 18 shipments · $438K · 4 Indian suppliers · 4 buyers
SHIPMENTS
18
USD
$438K
COUNTRIES
4
SUPPLIERS
4
BUYERS
4
HHI
3,338
concentrated
Top 4 destination countries in Europe
1
Romania (43.1%)
$189K
2
France (33.9%)
$148K
3
Russia (22.7%)
$100K
4
Ukraine (0.3%)
$1K
Top 4 Indian suppliers into Europe
1
SAVA HEALTHCARE LTD
$190K
2
TROIKAA PHARMACEUTICALS LTD
$133K
3
PANACEA BIOTEC PHARMA LTD
$100K
4
MEDNEXT BIOTECH LTD
$15K
Top 3 Europe importers
1
MOVI HEALTH LLC · Romania
$190K
2
PANBIO PHARM LLC · Russia
$100K
3
EURIMEX PHARMAPARC DACTIVITES ETRE · France
$15K
Top 2 dosage forms
1
Tablet
$339K
2
Capsule
$100K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $111K | $28K |
| Nov | 2 | $91K | $45K |
| Dec | 12 | $237K | $20K |
Shipment register · 18 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SAVA HEALTHCARE LTD · 11 shipments · $190K | |||||||||||
| 1 | Oct 2025 | MOVI HEALTH LLC | Romania | Tablet | 4.5K | NOS | $4.63 | $21K | MUNDRA SEA | Constanta | SEA |
| 2 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 2.4K | NOS | $8.09 | $19K | MUNDRA SEA | Constanta | SEA |
| 3 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 4.6K | NOS | $4.08 | $19K | MUNDRA SEA | Constanta | SEA |
| 4 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 4.7K | NOS | $3.96 | $19K | MUNDRA SEA | Constanta | SEA |
| 5 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 9.0K | NOS | $4.76 | $43K | MUNDRA SEA | Constanta | SEA |
| 6 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 9.2K | NOS | $2.62 | $24K | MUNDRA SEA | Constanta | SEA |
| 7 | Dec 2025 | MOVI HEALTH LLC | Romania | Tablet | 4.6K | NOS | $9.72 | $45K | MUNDRA SEA | Constanta | SEA |
| 8 | Dec 2025 | MOVI HEALTH LLC | Ukraine | Tablet | 120 | NOS | $4.76 | $571.57 | MUMBAI AIR (SAHAR) | KIEV | AIR |
| 9 | Dec 2025 | MOVI HEALTH LLC | Ukraine | Tablet | 90 | NOS | $2.62 | $235.91 | MUMBAI AIR (SAHAR) | KIEV | AIR |
| 10 | Dec 2025 | MOVI HEALTH LLC | Ukraine | Tablet | 60 | NOS | $4.08 | $244.78 | MUMBAI AIR (SAHAR) | KIEV | AIR |
| 11 | Dec 2025 | MOVI HEALTH LLC | Ukraine | Tablet | 60 | NOS | $3.96 | $237.44 | MUMBAI AIR (SAHAR) | KIEV | AIR |
| SUPPLIER #2 — TROIKAA PHARMACEUTICALS LTD · 3 shipments · $133K | |||||||||||
| 12 | Oct 2025 | UNKNOWN BUYER | France | Tablet | 8.6K | NOS | $4.07 | $35K | AHMEDABAD ICD | ROUEN | ICD |
| 13 | Oct 2025 | UNKNOWN BUYER | France | Tablet | 9.8K | NOS | $4.06 | $40K | AHMEDABAD ICD | ROUEN | ICD |
| 14 | Nov 2025 | UNKNOWN BUYER | France | Tablet | 14.7K | NOS | $3.98 | $58K | AHMEDABAD ICD | ROUEN | ICD |
| SUPPLIER #3 — PANACEA BIOTEC PHARMA LTD · 3 shipments · $100K | |||||||||||
| 15 | Nov 2025 | PANBIO PHARM LLC | Russia | Capsule | 664.7K | NOS | $0.049 | $32K | DELHI AIR | SHEREMETYEVO | AIR |
| 16 | Dec 2025 | PANBIO PHARM LLC | Russia | Capsule | 1.3M | NOS | $0.050 | $67K | DELHI AIR | SHEREMETYEVO | AIR |
| 17 | Dec 2025 | PANBIO PHARM LLC | Russia | Capsule | 332.4K | NOS | $0.0006 | $203.21 | DELHI AIR | MOSCOW DOMODEDOVO | SEA |
| SUPPLIER #4 — MEDNEXT BIOTECH LTD · 1 shipments · $15K | |||||||||||
| 18 | Oct 2025 | EURIMEX PHARMAPARC DACTIVITES ETRE | France | Tablet | 2.9K | NOS | $5.23 | $15K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
3 countries · 4 shipments · $75K · 3 Indian suppliers · 3 buyers
SHIPMENTS
4
USD
$75K
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
5,155
concentrated
Top 3 destination countries in Americas
1
El Salvador (61.7%)
$46K
2
Guatemala (36.7%)
$27K
3
Haiti (1.6%)
$1K
Top 3 Indian suppliers into Americas
1
CAPLIN POINT LABORATORIES LTD
$46K
2
XL LABORATORIES PVT LTD
$27K
3
AXON DRUGS PVT LTD
$1K
Top 3 Americas importers
1
DROGUERIA SAIMED S.A DE C.V · El Salvador
$46K
2
FUTURA, SOCIEDAD ANONIMA · Guatemala
$27K
3
PROPHARMA S.A · Haiti
$1K
Top 2 dosage forms
1
Tablet
$47K
2
Granules
$27K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $27K | $14K |
| Nov | 1 | $46K | $46K |
| Dec | 1 | $1K | $1K |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CAPLIN POINT LABORATORIES LTD · 1 shipments · $46K | |||||||||||
| 1 | Nov 2025 | DROGUERIA SAIMED S.A DE C.V | El Salvador | Tablet | 768.0K | NOS | $0.060 | $46K | KAMARAJAR PORT SEA | Acajutla | SEA |
| SUPPLIER #2 — XL LABORATORIES PVT LTD · 2 shipments · $27K | |||||||||||
| 2 | Oct 2025 | FUTURA, SOCIEDAD ANONIMA | Guatemala | Granules | 4.1K | NOS | $3.33 | $14K | TUGHLAKABAD ICD | Puerto Quetzal | ICD |
| 3 | Oct 2025 | FUTURA, SOCIEDAD ANONIMA | Guatemala | Granules | 4.1K | NOS | $3.33 | $14K | TUGHLAKABAD ICD | Puerto Quetzal | ICD |
| SUPPLIER #3 — AXON DRUGS PVT LTD · 1 shipments · $1K | |||||||||||
| 4 | Dec 2025 | PROPHARMA S.A | Haiti | Tablet | 1.2K | NOS | $1.01 | $1K | TONDIAPET ICD | PORT-AU-PRINCE | ICD |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 24 Indian glucosamine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped glucosamine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | SAVA HEALTHCARE LTD | WADHWAN CITY | 11 | $190K | Tablet | Europe |
| 2 | TROIKAA PHARMACEUTICALS LTD | MAHESANA | 3 | $133K | Tablet | Europe |
| 3 | PANACEA BIOTEC PHARMA LTD | BADDI | 3 | $100K | Capsule | Europe |
| 4 | MEDREICH LTD | BENGALURU | 2 | $74K | Capsule, Tablet | Asia |
| 5 | CAPLIN POINT LABORATORIES LTD | Puducherry | 1 | $46K | Tablet | Americas |
| 6 | ASOJ SOFT CAPS PVT LTD | VADODARA | 2 | $43K | Softgel Capsule | Africa |
| 7 | THE MADRAS PHARMACEUTICALS | CHENNAI | 1 | $29K | Tablet | Africa |
| 8 | XL LABORATORIES PVT LTD | BHIWADI | 2 | $27K | Granules | Americas |
| 9 | OXFORD LABORATORIES PVT LTD | MUMBAI | 1 | $18K | Asia | |
| 10 | MEDNEXT BIOTECH LTD | UDAIPUR | 1 | $15K | Tablet | Europe |
| 11 | ANVIS LABORATORIES PVT LTD | MUMBAI | 2 | $6K | Tablet | Asia |
| 12 | ZEE LABORATORIES LTD | HARYANA | 2 | $4K | Tablet | Asia |
| 13 | COMED CHEMICALS LTD | RANIA | 1 | $3K | Tablet | Africa |
| 14 | REGAL LABORATORIES | TARN TARAN | 1 | $1K | Tablet | Africa |
| 15 | AXON DRUGS PVT LTD | TAMIL NADU | 1 | $1K | Tablet | Americas |
| 16 | NUMED PHARMA DISTRIBUTOR | MANGAON | 2 | $699.21 | Tablet | Africa |
| 17 | CURE EARTH PHARMA | Chennai | 1 | $581.36 | Capsule | Africa |
| 18 | BAKER & DAVIS PVT LTD | MUMBAI | 2 | $219.63 | Tablet | Africa |
| 19 | GOOD HEALTH PHARMA | CHENNAI | 1 | $71.86 | Other | Asia |
| 20 | MERCURY MEDICARE | CHENNAI | 2 | $58.65 | Tablet | Asia |
| 21 | RUSHI MARKETING | AHMEDABAD | 1 | $36.86 | Africa | |
| 22 | DISTINCT IMPEX PVT LTD | MUMBAI | 2 | $31.21 | Tablet | Asia |
| 23 | VEA IMPEX (I) PVT LTD | MUMBAI | 2 | $29.96 | Tablet | Africa |
| 24 | AL-SUPREME EXPORTS | NAGERCOIL | 1 | $1.91 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 21 global glucosamine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian glucosamine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MOVI HEALTH LLC | Romania | 11 | $190K | SAVA HEALTHCARE LTD | Tablet |
| 2 | PANBIO PHARM LLC | Russia | 3 | $100K | PANACEA BIOTEC PHARM… | Capsule |
| 3 | PHARMAZEN MEDICALS PTE LTD | Singapore | 1 | $67K | MEDREICH LTD | Capsule |
| 4 | DROGUERIA SAIMED S.A DE C.V | El Salvador | 1 | $46K | CAPLIN POINT LABORAT… | Tablet |
| 5 | LYMENS MEDICAL SUPPLIES LTD | Ghana | 1 | $29K | THE MADRAS PHARMACEU… | Tablet |
| 6 | FUTURA, SOCIEDAD ANONIMA | Guatemala | 2 | $27K | XL LABORATORIES PVT … | Granules |
| 7 | TOO ANADHI | Kazakhstan | 1 | $18K | OXFORD LABORATORIES … | |
| 8 | EURIMEX PHARMAPARC DACTIVITES ETRE | France | 1 | $15K | MEDNEXT BIOTECH LTD | Tablet |
| 9 | HEALOL PHARMACEUTICALS SDN BHD | Malaysia | 1 | $7K | MEDREICH LTD | Tablet |
| 10 | ARIA PHRAMA CO LTD | Afghanistan | 2 | $6K | ANVIS LABORATORIES P… | Tablet |
| 11 | NAWI FAQIRI LTD | Afghanistan | 2 | $4K | ZEE LABORATORIES LTD | Tablet |
| 12 | LEGIT MEDIQ 2007 LTD | Kenya | 1 | $3K | COMED CHEMICALS LTD | Tablet |
| 13 | SONIA PHARMACY | Equatorial Guinea | 1 | $1K | REGAL LABORATORIES | Tablet |
| 14 | PROPHARMA S.A | Haiti | 1 | $1K | AXON DRUGS PVT LTD | Tablet |
| 15 | LIFELINE PHARMACEUTICALS OF | Lesotho | 2 | $699.21 | NUMED PHARMA DISTRIB… | Tablet |
| 16 | KALKAAL HOSPITAL | Somalia | 1 | $581.36 | CURE EARTH PHARMA | Capsule |
| 17 | COCIETE BIKA MULTI ACTIVITIES | Chad | 1 | $109.81 | BAKER & DAVIS PVT LTD | Tablet |
| 18 | GKV GLOBAL SERVICES | Malaysia | 1 | $71.86 | GOOD HEALTH PHARMA | Other |
| 19 | SEQUENCE MEDICARE SDN BHD | Malaysia | 2 | $58.65 | MERCURY MEDICARE | Tablet |
| 20 | BAPA KAZADI | DR Congo | 1 | $36.86 | RUSHI MARKETING | |
| 21 | GOOD HEALTH (PTY) LTD | Seychelles | 1 | $1.91 | AL-SUPREME EXPORTS | Tablet |
This report covers 48 2025-Q4 Glucosamine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/glucosamine
Talk to our trade analyst
Need a custom glucosamine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/glucosamine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Glucosamine product page
Live data, supplier directory, price trends, and trade route analysis